Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function

Liver Transplantation

Volumn 14, Issue 1, 2008, Pages 59-65

  Cywinski, Jacek B ^a   Mascha, Edward ^b   Miller, Charles ^b   Eghtesad, Bijan ^b   Nakagawa, Shunichi ^b   Vincent, Joseph P ^b   Pesa, Nick ^c   Na, Jie ^b   Fung, John J ^b   Parker, Brian M ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN; FRESH FROZEN PLASMA; HTK SOLUTION; SODIUM; UNIVERSITY OF WISCONSIN SOLUTION;

ADULT; ARTICLE; CADAVER DONOR; COLD ISCHEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; ERYTHROCYTE COUNT; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HYPERNATREMIA; HYPONATREMIA; INTENSIVE CARE UNIT; INTRAOPERATIVE PERIOD; LENGTH OF STAY; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SODIUM BLOOD LEVEL; SURGICAL MORTALITY; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; HYPERNATREMIA; HYPONATREMIA; LIVER FAILURE; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; SODIUM; SURVIVAL RATE; TISSUE DONORS;

EID: 38649093986     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21305     Document Type: Article

References (11)

1. Totsuka E, Dodson F, Urakami A, Moras N, Ishii T, Lee MC, et al. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Liver Transpl 1999;5:421-428.
2. Totsuka E, Fung JJ, Hakamada K, Tanaka M, Takahashi K, Nakai M, et al. Analysis of clinical variables of donors and recipients with respect to short-term graft outcome in human liver transplantation. Transplant Proc 2004;36: 2215-2218.
3. Alsharabi A, Cielak B, Nyckowski P, Zieniewicz K, Patkowski W, Pawlak J, et al. Biochemical assessment of the early liver graft function in relation to selected donor parameters. Transplant Proc 2003;35:2256-2259.
4. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidcnce-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006; 130:1652-1660.
5. Londono MC, Guevara M, Rimola A, Navasa M, Taura P, Mas A, et al. Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology 2006;130:1135-1143.
6. Powner DJ. Factors during donor care that may affect liver transplantation outcome. Prog Transplant 2004:14:241-247.
7. Kim DJ, Lee SK, Jo JW, Kim SJ, Kwon CH, Park JW, et al. Prognosis after liver transplantation predicted by preoperative MELD score. Transplant Proc 2006;38:2095-2096.
8. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005; 11:336-343.
9. Onaca NN, Levy MF, Netto GJ, Thomas MJ, Sanchez EQ, Chinnakotla S, et al. Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transplant 2003;3:626-630.
10. Onaca NN, Levy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ, et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003;9:117-123.
11. Brown RS Jr, Kumar KS, Russo MW, Kinkhabwala M, Rudow DL, Harren P, et al. Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl 2002;8: 278-284.